Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Liestal
Clinical trial register · Switzerland

Clinical Trials in Liestal, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Switzerland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2249 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:18 UTC
2249
Studies in scope
all four open statuses
1364
Recruiting now
open to new participants
528
Lead sponsors
across recruiting studies
Top sites
Zurich 739 Bern 722 Basel 636 Geneva 406 Lausanne 394
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Basel, Switzerland9 Fondazione Epatocentro Ticino3 AstraZeneca3 Prof. Dr. Jörg Leuppi3 Daiichi Sankyo2 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2 Stemline Therapeutics, Inc.1 European Organisation for Research and Treatment of Cancer - EORTC1 Andrea Goldmann1 Medical Research Council1 Drahomir Aujesky1 AO Innovation Translation Center1 Novartis Pharmaceuticals1 Eva Heim1 Gilead Sciences1 Swiss Cancer Institute1 University of Zurich1 Inspire Medical Systems, Inc.1 Nyxoah S.A.1
Site location
Zurich739 Bern722 Basel636 Geneva406 Lausanne394 Sankt Gallen272 Lucerne152 Bellinzona148 Aarau136 Lugano131 Chur99 Baden81 Winterthur81 Fribourg72 Liestal35 Olten32 Sion24 Frauenfeld22 Thun19 Münsterlingen15 Nottwil15 Biel14 Neuchâtel13 Solothurn12 Meyrin12 Show all 151
All 151 locations
Target enrolment
to

Trials with a site in Liestal

35 of 2249 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Switzerland
Start
Recruiting
University Hospital, Basel, Switzerland
Observational
4,300
Liestal, Basel
2026-10-01
Recruiting
AstraZeneca
Phase 3
150
Basel, Liestal, Rennaz
2026-06-15
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Basel, Bern, Geneva, Lausanne, Liestal, Zurich
2026-05-11
Recruiting
Prof. Dr. Jörg Leuppi
Not applicable
120
Liestal
2026-02-05
Recruiting
Eva Heim
Not applicable
288
Liestal, Aarau, Basel, Wabern, Lausanne, Yverdon-les-Bains, Winterthur
2026-01-21
Recruiting
Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
NCT06963203Graves Disease, Amiodarone-Induced Thyrotoxicosis, Thyroidectomy
Andrea Goldmann
Observational
486
Zurich, Basel, Bern, Geneva, Lausanne, Liestal, Männedorf, Mendrisio
2025-07-01
Recruiting
EURO-STIM Registry
NCT06971796Obstructive Sleep Apnea, Obstructive Sleep Apnea (OSA)
Inspire Medical Systems, Inc.
Observational
1,000
Liestal
2025-05-26
Recruiting
AstraZeneca
Phase 3
600
Frauenfeld, Liestal, Sankt Gallen, Zurich
2025-03-27
Recruiting
University Hospital, Basel, Switzerland
Not applicable
400
Aarau, Basel, Bern, Biel, Chur, Geneva, Lausanne, Liestal
2025-02-10
Recruiting
Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
NCT06358573Triple-negative Breast Cancer, TNBC - Triple-Negative Breast Cancer
DrugINT230-6
Swiss Cancer Institute
Phase 2
61
Aarau, Basel, Bellinzona, Chur, Liestal, Sankt Gallen, Winterthur, Zurich
2024-10-24
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Aarau, Baden, Liestal, Basel, Sankt Gallen, Lausanne, Winterthur, Zurich
2024-09-27
Recruiting
University Hospital, Basel, Switzerland
Phase 4
100
Baden, Basel, Liestal, Sankt Gallen
2024-06-24
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Baden, Frauenfeld, Fribourg, Geneva, La Chaux-de-Fonds, Lausanne, Liestal, Sankt Gallen
2023-10-24
Active, closed
University of Zurich
Not applicable
49
Liestal, Bern, Lucerne, Winterthur, Zurich
2023-03-10
Active, closed
Daiichi Sankyo
Phase 3
1,233
Liestal, Sankt Gallen, Thun
2023-01-11
Recruiting
Digital Voice Analysis as a Measure of Frailty and Distress
NCT05783401Frailty, Distress, Emotional
University Hospital, Basel, Switzerland
Observational
100
Basel, Liestal
2022-11-19
Recruiting
University Hospital, Basel, Switzerland
Observational
232
Basel, Liestal
2022-09-26
Active, closed
Gilead Sciences
Phase 3
443
Baden, Liestal, Sankt Gallen, Winterthur, Zurich
2022-07-25
Active, closed
Daiichi Sankyo
Phase 3
740
Baden, Basel, Liestal, Sankt Gallen
2022-03-04
Recruiting
University Hospital, Basel, Switzerland
Not applicable
200
Liestal, Basel
2021-08-01
Active, closed
AstraZeneca
Phase 3
1,371
Liestal, Zurich
2021-01-28
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Baden, Basel, Bern, Binningen, Davos, Lachen, Lausanne, Liestal
2021-01-15
Recruiting
University Hospital, Basel, Switzerland
Observational
3,000
Basel, Liestal
2020-10-01
Recruiting
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
NCT04263038Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases
DrugRivaroxaban
Drahomir Aujesky
Phase 4
276
Liestal, Aarau, Bern, Biel/Bienne, Fribourg, Lucerne, Olten, Sankt Gallen
2020-05-15
Active, closed
Nyxoah S.A.
Not applicable
110
Liestal
2019-09-01
Recruiting
Swiss Severe Asthma Register
NCT03984253Severe Asthma
Prof. Dr. Jörg Leuppi
Observational
600
Liestal, Bern, Chur, Davos, Geneva, Lausanne, Lugano, Sankt Gallen
2019-05-13
Recruiting
Periprosthetic Fracture Registry (PPFx)
NCT03378557Periprosthetic Fractures, Periprosthetic Fracture Around Prosthetic Joint Implant
AO Innovation Translation Center
Observational
600
Basel, Liestal, Zurich
2018-12-31
Recruiting
Taper Or Abrupt Steroid Stop: TOASSTtrial
NCT03153527Inflammatory Disorder, Autoimmune
DrugPrednisone
University Hospital, Basel, Switzerland
Phase 4
530
Aarau, Baden, Basel, Bern, Bülach, Frauenfeld, Geneva, Liestal
2017-05-31
Recruiting
Swiss Primary Sclerosing Cholangitis Cohort Study
NCT03146936Cholangitis, Sclerosing, PSC, Primary Sclerosing Cholangitis (PSC)
Fondazione Epatocentro Ticino
Observational
120
Lugano, Basel, Bern, Bülach, Chur, Geneva, Lausanne, Liestal
2017-02-28
Recruiting
Swiss Autoimmune Hepatitis Cohort Study
NCT03146884Hepatitis, Autoimmune, Autoimmune Hepatitis
Fondazione Epatocentro Ticino
Observational
500
Lugano, Basel, Bern, Chur, Geneva, Lausanne, Liestal, Lucerne
2017-02-16
Recruiting
Swiss Primary Biliary Cholangitis Cohort Study
NCT03146910PBC, Primary Biliary Cholangitis
Fondazione Epatocentro Ticino
Observational
500
Lugano, Basel, Bern, Bülach, Chur, Geneva, Lausanne, Liestal
2017-02-15
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Observational
200
Baden, Basel, Bern, Biel, Herisau, Lausanne, Liestal, Lucerne
2010-12
Active, closed
University Hospital, Basel, Switzerland
Observational
3,500
Liestal, Lachen, Basel, Lucerne, Zurich
2010-04
Recruiting
Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort
NCT02065921Chronic Obstructive Pulmonary Disease, COPD Exacerbation
Prof. Dr. Jörg Leuppi
Observational
265
Liestal
2006-09
Active, closed
Medical Research Council
Phase 2/3
11,992
Lausanne, Winterthur, Chur, Aarau, Basel, Bern, Liestal, Sankt Gallen
2005-07-08
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swiss investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-switzerland/city/liestal

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Switzerland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,249 studies in total at the last sync on 12 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies with a site in Liestal.

How many clinical trials are recruiting in Liestal?

23 of the 35 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 12 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Liestal), 35 studies
PhaseStudiesRecruitingShare
Observational161345.7%
Phase 38222.9%
Not applicable6417.1%
Phase 4338.6%
Phase 2112.9%
Phase 2/3102.9%

Most active sponsors

Lead sponsors with the most studies (Liestal)
Lead sponsorStudiesRecruiting
University Hospital, Basel, Switzerland98
AstraZeneca32
Fondazione Epatocentro Ticino33
Prof. Dr. Jörg Leuppi33
Daiichi Sankyo20
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company21
Andrea Goldmann11
AO Innovation Translation Center11
Drahomir Aujesky11
European Organisation for Research and Treatment of Cancer - EORTC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.